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Major depressive disorder (MDD) occurs with a high prevalence among mental illnesses.
MDD patients experience sadness and hopelessness, with blunted affective reactivity.
However, such depressive episodes are also key symptoms in other depressive disorders,
like Bipolar Disorder (BPD) or Seasonal Affective Disorder (SAD). Moreover, depressive
symptoms can also be found in healthy individuals, but are experienced as less severe
or for a shorter duration than in patients. Here, it is aimed to summarize studies
investigating odor perception in depression, including depressive states in healthy
individuals and patient populations. Odor perception in depression has been assessed
with psychophysical methods (olfactory sensitivity, odor identification, and discrimination),
and odor ratings (intensity, emotional valence, familiarity). In addition, some studies
investigated affective reactions to odors, and physiological and anatomical correlates
of odor perception in depression. The summary reveals that MDD is associated with
reduced olfactory sensitivity. However, odor identification and discrimination scores seem
to be unaffected by depression. The reduced olfactory sensitivity might be associated
with a reduced ability to encode olfactory information and a reduced volume of the
olfactory bulb. While similar processes seem to occur in healthy individuals experiencing
depressive states, they have not been observed in BPD or SAD patients. However, in
order to conclude that the reduced olfactory sensitivity is directly linked to depression, it is
suggested that studies should implement control measures of cognitive performances or
perceptual abilities in other stimulus modalities. It is concluded that the reduced olfactory
performance in MDD patients seems to be disorder-, modality-, and test-specific, and that
the application of an appropriate olfactory and cognitive test-battery might be highly useful
in the differential diagnosis of MDD.
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INTRODUCTION
Everybody knows the feeling of sadness as a transient mood state.
Sadness is considered to be one of six basic emotions, all of
which being experienced in healthy humans independent of cul-
ture (anger, disgust, fear, happiness, sadness, and surprise; Ekman
and Davidson, 1994). Several brain areas involved in cerebral pro-
cessing of these emotions are described (Panksepp, 2011; LeDoux,
2012), with sad states being regulated most prominently by the
anterior cingulate cortex and the dorsomedial prefrontal cortex
(Murphy et al., 2003). But what kind of feelings and behavior
differentiate the normal experience of transient sadness from an
affective state of depression? The clinical categories and diagnostic
criteria for mood and other mental disorders can be assessed via
the diagnostic and statistical manual of mental disorders (DSM-5,
American Psychiatric Association, APA, 2013).
Whereas in former times (DSM IV; APA, 2000) depression
belonged to the category of affective disorders that included
unipolar and bipolar depressive disorders, in the present view
both disorders are clearly separated from each other (DSM-5,
APA, 2013). Among the unipolar depressive disorders, the two
most prevalent disorders are Major Depressive Disorder (MDD)
and Dysthymia. Both of them share the key symptoms of a
depressed mood and a loss of interest or pleasure. However, MDD
patients strongly suffer from the depressive mood during at least
a 2-weeks period, while in Dysthymia patients, the depressive
mood is less severe but lasts at least for 2 years. Bipolar disor-
ders (BPDs) on the other hand, differ from unipolar depressive
disorders in the experience of manic (Bipolar Disorder I, BPD I)
or hypomanic episodes (Bipolar Disorder II, BPD II), states of
abnormally elevated physical or mental activity, usually accom-
panied by an inflated self-esteem. In BPD patients, the manic
phases often alternate with depressive episodes. Both, BPD and
MDD, can occur with a seasonal pattern, with depressive episodes
regularly reoccurring during fall or winter time.
MDD as well as BPD are described to include one or more
major depressive episodes. Therefore, the occurrence of an
episode of major depression is not a diagnostic category by itself.
The criteria of a major depressive episode are as follows: dur-
ing 2 weeks nearly the whole time, at least five of the following
symptoms have to be present: depressive mood like sadness or
hopelessness, reduced interest in activities, significant loss of
appetite or increased appetite as well as weight loss or weight-gain
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without going on a diet, insomnia or hypersomnia, increased psy-
chomotor agitation or retardation, fatigue, feelings of worthless-
ness, diminished ability to concentrate, and thoughts of suicide.
Regarding these symptoms, MDD and BPD are mood disor-
ders affecting functions of motor behavior, perception, memory,
cognition, and motivation.
Among all mental disorders, MDD occurs with a high preva-
lence. The 12-month prevalence in the United States is approx-
imately 7%, with females experiencing 1.5–3-fold higher rates
thanmales.With a 12-month prevalence of 0.6%, BPD has a lower
prevalence than MDD (USA, APA, 2013).
There are several theories explaining different aspects of MDD.
Cognitive approaches focus on biased information processing
and dysfunctional beliefs about the self, the outside world and
the future (Beck, 1979). Studies using neuroimaging techniques
show alterations of cerebral blood flow and metabolic differ-
ences between depressed patients and healthy controls in the
amygdala and anatomically related areas of the prefrontal cortex
(see Drevets, 2003). Moreover, it is suggested that dysfunctions
in the serotonin receptor and other monoaminergic systems
could lead to MDD (see Savitz et al., 2009; Savitz and Drevets,
2013). Recently, it has been shown that the deviant serotoner-
gic neurotransmission seems to be responsible for a decoupled
cingulated-amygdala-interaction (Pezawas et al., 2005).
Depressive episodes occurring predominately during a partic-
ular time of the year (e.g., in the fall or winter) have been termed
Seasonal Affective Disorder (SAD). The underlying mechanisms
of SAD, MDD, or BPD are supposed to be different, consider-
ing the improvement of SAD symptoms, but not MDD or BPD
symptoms, through light therapy (exposure to a standard regi-
men of 10,000 lux cool-white fluorescent light, e.g., Eastman et al.,
1998). In SAD, functional deviations within the suprachiasmatic
nucleus of the hypothalamus are described (Krout et al., 2002).
The suprachiasmatic nucleus is a central structure that medi-
ates behavioral responses induced by the change in the length of
daylight.
As mentioned before, alterations of cerebral blood flow and
metabolism in the limbic cingulated cortex and prefrontal cortex
are consistently observed in MDD patients. Within these brain
areas, the amygdala and the ventromedial (orbitofrontal) pre-
frontal cortex seem to be the most affected in MDD patients
(Murray et al., 2011). As well as in emotional processing (LeDoux,
2007), the amygdala is inherently involved in the processing
of odor perception (Soudry et al., 2011) and is part of the
primary olfactory cortex (Carmichael et al., 1994). From the
amygdala olfactory information can be directly transmitted to
the orbitofrontal cortex, which is the main neocortical relay for
olfactory information (Carmichael et al., 1994; Gottfried, 2006).
According to this overlap in odor and emotion processing struc-
tures, affective disorders like MDD should accompany alterations
of olfactory perception.
Human olfaction has been divided into hierarchical orga-
nized levels that are characterized as either primary or secondary.
As described by Martzke et al. (1997), olfactory sensitivity is a
part of a primary and sensory level of stimulus processing in
the olfactory system. However, abilities like olfactory identifica-
tion, discrimination or odor recognition and odor ratings belong
to the secondary and evaluative level of olfaction. The various
functions of the olfactory system are to be assessed by suit-
able methods (Weierstall and Pause, 2012). Most tests for the
assessment of olfactory functions fall into three main classes:
threshold (absolute sensitivity), identification, and discrimina-
tion. Olfactory sensitivity is understood as a measure of the lowest
concentration of a particular olfactory stimulus required to acti-
vate the receptor neurons resulting in the detection of that odor
(Martzke et al., 1997). For the assessment of the odor threshold,
a staircase threshold procedure (Bekesy, 1947; Doty, 1991) has
been developed that can be used with several odors (Doty and
Laing, 2003). This threshold test has been adopted by numerous
laboratories (e.g., Pause et al., 2001; Lötsch et al., 2008).
Odor identification is a measure of an individual’s ability to
perceive and name an odor. Three types are common: first, a sim-
ple naming task, prompting the individual to supply a name for a
given odor; second, a yes-no odor identification test, in which the
participant has to decide whether the odor presented matches a
given verbal label or not; or third, a multiple choice odor identifi-
cation test, with a list of odor names provided for each stimulus.
The 40-item, multiple choice University of Pennsylvania Smell
Identification Test (UPSIT) is widely used to assess identification
performance (Doty et al., 1984b). In the UPSIT, the participant
has to choose the odor quality of a given odor out of four ver-
bal descriptors. An odor identification test is also included in
the Sniffin’ Sticks test battery (Hummel et al., 2007), which is
constructed similar to the UPSIT but contains 16 items only.
Odor discrimination is defined as a measure of an individual’s
ability to differentiate between a set of odors. The most simple
form is to state whether two odors are the same or different.
However, common tasks involve participants picking out the odd
odor out of a series of odors, all of which identical except for
one. The only commercially available odor discrimination test is
included in the Sniffin’ Sticks (Hummel et al., 2007). It comprises
16 items, of which participants are required to choose the odd
stimulus out of three given odors.
Psychological attributes of odors are assessed mainly with
regard to their intensity, hedonic aspects (pleasantness and
unpleasantness) or familiarity. Rating scales can be used to esti-
mate the relative amount of a psychological attribute perceived by
an individual. According to Doty and Laing (2003) in chemosen-
sory assessment, two types are popular: category scales, and
analog scales. Using category scales, the relative amount of a
sensation is signified by indicating which of a series of discrete
categories best describes the sensation. Using visual analog scales,
the strength of the sensation is indicated by placing a mark along
a line that might have descriptors (termed anchors) located at
its extremes (e.g., very weak—very strong). Contrary to olfac-
tory sensitivity, odor evaluations are suprathreshold procedures
mostly and therefore part of the secondary cognitive evaluative
level of the olfactory processing system. For some odors, pleas-
antness and intensity are closely related psychological dimensions
and negatively correlated (Doty, 1975).
In the following review, psychophysical and neurophysiologi-
cal findings of olfactory performances (sensitivity, identification,
discrimination, and odor ratings) in depressed patients (MDD,
BPD, SAD) and in healthy individuals experiencing only some
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depressive symptoms or a transient state of sad mood will be
summarized. By expanding this review to healthy people and
including the recent literature, this review will add on existing
summaries on olfaction and depression (Settle and Amsterdam,
1991; Serby et al., 1992; Atanasova et al., 2008; Burón and
Bulbena, 2013).
METHODS
Literature research was based on PubMed (National Center for
Biotechnology Information, Bethesda, MDUSA). Only studies
investigating distinct groups of MDD, BPD, or SAD patients were
included. Mixed samples consisting of BPD and MDD patients
in one group or different psychiatric patients in one group were
excluded. Further, only publications on chemical perception of
standard odors were taken into account. Publications regarding
the perception of body odors were not considered, because body
odors might be processed by different systems than the olfactory
system (Pause, 2012). As it was aimed to focus on the distinct
emotional experience of sadness, studies examining olfaction in
personality disorders were excluded from the literature search.
Finally, effects of odors on mood or therapeutic effect of odors
were not considered.
FINDINGS ON OLFACTORY FUNCTION IN DEPRESSION
Research on olfactory dysfunction in patients with depressive
disorders mainly focused on psychophysical assessment of olfac-
tory perception. Particularly, olfactory sensitivity, identification
and odor ratings including evaluations of odor characteristics
like pleasantness, unpleasantness, intensity or familiarity were
investigated. To a lesser extent, patients with depressive disorders
have been examined with reference to psychophysiological and
neuroanatomical aspects of odor perception, like chemosensory
event-related potentials (CSERPs, Pause et al., 2003) or the vol-
ume of the olfactory bulb (Negoias et al., 2010). In the following
sections, we will review the psychophysics, psychophysiology, and
neuroanatomy of olfactory perception in patients with depressive
disorders.
OLFACTORY SENSITIVITY IN DEPRESSIVE DISORDERS
Almost all studies regarding olfactory acuity in MDD indicate
that olfactory sensitivity is reduced (corresponding to elevated
detection thresholds) in patients, as compared to healthy con-
trols (Table 1). Pause et al. (2001) examined olfactory sensitivity
in medicated patients with acute MDD. The Beck’s depression
score (BDI; Beck et al., 1961) was 28.5 ± 11.4 in the patient
group. Olfactory thresholds for eugenol (clove-like odor) and
phenyl-ethylalcohol (PEA, rose-like odor) were determined using
a two-alternative staircase detection procedure (Bekesy, 1947;
Doty, 1991). The study showed reduced olfactory sensitivity in
MDD patients compared to healthy controls. Similarly, Thomas
et al. (2002) reported slightly (p < 0.10) elevated thresholds in
a sample of 16 unselected depressives without comorbidity and
with a mean BDI-Score of 23.8 ± 9.5. In line with these studies,
Lombion-Pouthier et al. (2006) reported sensitivity impairments
in patients with severe depression (without any comorbidity) and
a BDI-Score of 23.8 ± 5.7. Olfactory perception was assessed by
means of the Test Olfactif. The Test Olfactif evaluates olfactory
sensitivity using L-carvone and tetrahydrothiopene (forced choice
procedure for 5 successive concentrations). Odor detection and
identification performance are examined with a panel of 16 odors.
Participants have to choose the odor bottle out of four bottles
(detection task) and they are asked to choose the correct odor
label among a list of four labels (indentification task). Negoias
et al. (2010) also showed sensitivity impairments inMDDpatients
[comorbidities (somatoform disorders, posttraumatic stress dis-
order and anxiety disorders) were accepted for inclusion] with a
mean BDI-Score of 29.7± 10.8. All participants were screened for
possible cognitive impairments by themini mental state examina-
tion (MMSE, Folstein et al., 1975) and olfactory thresholds were
assessed by the Sniffin’ Sticks (Hummel et al., 2007) with PEA in
16 dilutions.
Two studies investigated whether the reduced olfactory sensi-
tivity is directly related to the depressive disorder or secondary
to the effects of antidepressant drugs. Serby et al. (1990, 1992)
examined a sample of 9 MDD patients with a mean Hamilton-
Depression-Score (HAM-D; Hamilton, 1960) of 19.9± 1.6 under
no antidepressant medication. They found a slightly (p < 0.10)
reduced olfactory sensitivity (elevated olfactory thresholds) to
geraniol in patients with MDD compared to healthy controls.
Pause et al. (2005) investigated 11 antidepressant drug-free MDD
patients. They found significantly elevated olfactory thresholds
(PEA and menthol) in patients with moderate MDD (BDI-Score
= 17.7 ± 6.9). These results support the conclusion that the
decline in olfactory sensitivity in MDD is directly related to the
disorder and not mediated by psychiatric treatment.
Gross-Isseroff et al. (1994) investigated olfactory thresholds
(androstenone and isoamylacetate) in 9 MDD patients, three
times during the course of their psychiatric treatment (HAM-D-
Score: Day 0: 24.1 ± 1.2, Day 21: 11.7 ± 1.1 and Day 42: 6.4 ±
0.6). They observed a significant increase in olfactory sensitivity
(only isoamylacetate) in MDD patients 6 weeks after initiation
of antidepressant drug treatment. This finding is in line with the
results from Pause et al. (2001) who showed that after success-
ful medical treatment, sensitivity impairments in MDD patients
were reduced. Further, Pause et al. (2001, 2005) and Negoias
et al. (2010) reported a significant negative correlation between
olfactory sensitivity and the severity of depression.
To our knowledge, only one study did not find any alter-
ations of olfactory thresholds in MDD patients (Swiecicki et al.,
2009). In this patient group, the mean HAM-D-Score was 15.2±
1.6 and the mean BDI-Score was 27.2 ± 2.8; olfactory thresh-
olds were assessed using the Sniffin’ Sticks (n-butanol). Only
non-demented (MMSE-score > 24) patients without another
psychiatric disorder were included. However, according to the
authors, in many of the depressed patients, pharmacotherapy
had led to improvement in depressive symptomatology before
inclusion to the study. Hence, in line with the findings of Gross-
Isseroff et al. (1994) and Pause et al. (2001) successful psychiatric
treatment in MDD seems to renormalize olfactory performance.
While the vast majority of studies have investigated odor per-
ception in MDD patients, few studies have examined olfactory
sensitivity in related depressive disorders. Swiecicki et al. (2009)
reported no differences of olfactory thresholds in patients with
BPD, suggesting that sensory aspects of olfactory function cannot
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Table 1 | Summary of studies of olfactory sensitivity in affective disorders.
Study Number of participants
(f/m) and diagnosis
Mean age ± SD Severity-scores Odorants and test
method
Olfactory
sensitivity
Gross-Isseroff et al.,
1994
C: 9 (8/1)
P: 9 (8/1); MDD
C: 49,11 ± 4.82
P: 49.00 ± 4.56
P: 24.11 ± 1.17
(Day 0),
11.67 ± 1.13 (Day 21),
6.44 ± 0.58 (Day 42,
HAM-D)
Androstenone,
isoamyl acetate,
three way forced
choice ascending
method
Day 0 and Day 21:
P = C,
Day 42: P > C
(isoamyl acetate)
Krüger et al., 2006 BPD + ETE: 7 (1/6)
BPD – ETE: 9 (5/4)
BPD + ETE:
33.9 ± 10.7
BPD – ETE:
46.1 ± 11.6
BPD + ETE:
0.8 ± 1 (HAM-D)
0.8± 1.2 (SRMI)
BPD – ETE:
0.4 ± 0.7 (HAM-D)
1.4 ± 1 (SRMI)
PEA, Sniffin’ Sticks BPD + ETE >
BPD – ETE
Lombion-Pouthier
et al., 2006
C: 58 (36/22)
P: 49 (35/14);
MDD
C: 38.4 ± 13.96
P: 43.4 ± 17.54
P: 23.75 ± 5.74 (BDI) L-carvone,
tetrahydrothiopene,
Test Olfactif
P < C
Negoias et al., 2010 C: 21 (15/6)
P: 21 (17/4);
MDD
C: 39.62 ± 11.39
P: 36.86 ± 10.13
P: 29.67 ± 10.84 (BDI) PEA, Sniffin’ Sticks,
laterized
P < C
Pause et al., 2001 1. Session:
C: 24 (15/9)
P: 24 (15/9); MDD
2. Session:
C: 18 (13/5)
P: 18 (13/5);
MDD in remission
C: 44.2 ± 12.6
P: 48.4 ± 13.2
C: 46.6 ± 12.8
P: 47.9 ± 13.4
C: 4.8 ± 2.5 (BDI)
P: 28.5 ± 11.4 (BDI)
C: 4.6 ± 3.4 (BDI)
P: 11.5 ± 7.1 (BDI)
PEA, eugenol,
2alt.-staircase
PEA, eugenol,
2alt.-staircase
P < C
P = C
Pause et al., 2005 C: 11 (6/5)
P: 11 (7/4);
MDD (drug-free)
C: 33.0 ± 8.6
P: 32.7 ± 5.5
C: 2.1 ± 2.3 (BDI)
P: 17.7 ± 6.9 (BDI)
PEA, menthol,
2alt.-staircase
P < C
Postolache et al.,
1999
C: 24 (17/7)
P: 24 (17/7); SAD
C: 42.1 ± 11.8
P: 42.8 ± 9.7
/ PEA, 2alt.-staircase P (SAD) = C
Postolache et al.,
2002
C: 16 (9/7)
P: 14(7/7); SAD
C: 39.0 ± 10.8
P: 42.3 ± 11.5
/ PEA, 2alt.-staircase P (SAD) > C
Serby et al., 1990,
1992
C: 9 (/)
P: 9 (0/9); MDD
(drug free)
C: 50 – 59
P: 50 – 59
P: 19.9 ± 1.6 (HAM-D) Geraniol,
forced-choice
ascending method
P < C (p < 0.1)
Swiecicki et al., 2009 C: 30 (20/10)
P: 46 (RDD:
20, BPD: 21)
C: 35.4 ± 2.1
RDD: 35.7 ± 2.3
BPD: 39.6 ± 2.5
C: 0.5 ± 0.3 (HAM-D), 1.9
± 0.5 (BDI)
RDD: 15.2 ± 1.6 (HAM-D),
27.2 ± 2.8 (BDI);
BPD: 14.1 ± 1.0 (HAM-D),
23.2 ± 1.8 (BDI)
n-butanol, Sniffin’
Sticks
RDD = BP = C
Thomas et al., 2002 C: 24
P: 16
(unselected depressed with
major depressive episode)
/ 23.8 ± 9.5 (BDI) / P < C (p < 0.1)
f, female; m, male; C, controls; P, patients; MDD, major depressive disorder; HAM-D, Hamilton Depression Rating-Scale; =, no difference between groups; P > C,
patients performed better than controls; P < C, patients performed worse than controls; BPD + ETE, bipolar disorder with event triggered episodes; BPD – ETE,
bipolar disorder without event triggered episodes; SRMI, Self-Report Manic Inventory; PEA, phenyl-ethylalcohol; BDI, Beck’s Depression Inventory; 2alt.-staircase,
two-alternative staircase detection procedure; SAD, Seasonal affective disorder; RDD, unipolar recurrent depressive disorder; BPD, bipolar disorder; /, no information
available.
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serve as a reliable indicator of patients’ polarity. Contrasting BPD
patients with and without a history of event-triggered episodes,
Krüger et al. (2006) showed in a pilot study that olfactory sen-
sitivity (as assessed by the Sniffin’ Sticks) was higher in patients
vulnerable to emotional stress (with event-triggered episodes,
n = 7) than in patients without event-triggered episodes (n = 9).
A healthy control group did not exist in this study.
To our knowledge, there are only two studies on olfactory
performance and SAD, however, with conflicting results. In one
study, Postolache et al. (1999) found no differences in olfac-
tory thresholds between patients (SAD without comorbidity) and
healthy controls or between patients before and after light treat-
ment (exposure to a standard regimen of 10,000 lux cool-white
fluorescent light therapy for 45min twice daily). In the other
study, Postolache et al. (2002) observed lower olfactory detection
thresholds (a higher olfactory acuity) in SAD patients compared
to controls regardless of season.
In summary, the presented evidence shows that olfactory sen-
sitivity is reduced in MDD. The olfactory impairment is directly
related to the affective state and is not affected by anti-depressive
medication. Furthermore, the decline in sensitivity is related to
the severity of MDD. After successful treatment the olfactory dys-
function in MDD patients disappears. Importantly, the decline
in olfactory sensitivity seems to be specifically related to MDD,
and has not been observed in other depressive disorders like BPD
or SAD. The disorder specificity indicates that the reduced olfac-
tory sensitivity is not caused by a general cognitive decline in
depressive disorders. However, only one study controlled cog-
nitive performances in MDD patients (Negoias et al., 2010).
Therefore, olfactory threshold measurements seem to serve as
a differential diagnostic tool and a reduced olfactory sensitivity
might play a role as a marker of MDD.
OLFACTORY IDENTIFICATION AND DISCRIMINATION ABILITIES IN
DEPRESSIVE DISORDERS
Odor identification
Most studies examining olfactory identification abilities in
depressive patients have not found differences compared to
healthy controls (Table 2). Using the UPSIT, Amsterdam et al.
(1987) found no impairments of odor identification ability in a
sample of MDD patients with HAM-D-Scores ranging from 18
to 37. Kopala et al. (1994) and Warner et al. (1990) replicated
these results, also measuring olfactory identification ability by the
UPSIT in MDD patients (Warner et al., 1990), or patients expe-
riencing a major depressive episode (Kopala et al., 1994). They
gave no information about the severity of depression. Pause et al.
(2003) asked 20 MDD patients (mean BDI-Score = 26.4 ± 9.3)
and 20 healthy controls (mean BDI-Score= 3.2± 3.2) to identify
the odors of PEA and isobutyraldehyde, presented via an olfac-
tometer. It was shown that the identification rates were similar in
patients and controls. Assessing patients with severe depression
(mean BDI-Score = 23.8 ± 5.7), Lombion-Pouthier et al. (2006)
found identification scores, as indicated by the Test Olfactif, to be
similar to those in the control group. In line with these results,
Swiecicki et al. (2009) reported no alteration of olfactory identi-
fication ability, measured by the Sniffin’ Sticks in MDD patients.
Themean HAM-D-Score was 15.2± 1.6 and the mean BDI-Score
was 27.2 ± 2.8 in the patient group. Using the Sniffin Sticks
as well, Negoias et al. (2010) showed no differences in olfactory
identification ability between healthy controls and MDD patients
(mean BDI-Score= 29.7± 10.8, ranging from 11 to 51). Another
study (Naudin et al., 2012) evaluated psychiatric patients dur-
ing acute episodes of depression and 6 weeks after antidepressant
treatment against healthy controls. On the identification task,
participants had to identify single odors (n = 8) from a list of
four descriptors. Regarding the participants’ odor identification
performances, there was no significant difference among the three
groups, considering all odors or each odor independently.
In three studies MDD patients’ identification performance
was compared to the identification performance in patients with
Alzheimer’s dementia (AD). Solomon et al. (1998) andMcCaffrey
et al. (2000) applied the Pocket Smell Test, a three-item short
version of the UPSIT to 20 MDD and 20 AD patients. In the
latter study the patients’ cognitive status was assessed by the
MMSE, revealing cognitive impairments in AD patients but not
in MDD patients. The authors found that depressive patients
scored significantly better on the identification test than AD
patients, thereby, resembling the performance of healthy controls.
Pentzek et al. (2007) investigated odor identification performance
bymeans of the Sniffin’ Sticks in 20 AD patients, 20MDDpatients
and 30 healthy controls. Whereas MDD patients did not differ
from healthy participants in their cognitive status (evaluated by
the German version of the Alzheimer’s disease assessment scale;
Ihl and Weyer, 1993), AD patients showed a significant cogni-
tive decline compared to the two other groups. With respect
to the odor identification test, AD patients performed signifi-
cantly worse than MDD patients and the control group, whereas
MDD patients and healthy controls did not differ in their odor
identification ability.
Few studies have shown reduced olfactory identification abil-
ity in depressed patients. First, Serby et al. (1990, 1992) reported
odor identification deficits in patients with MDD (mean HAM-
D-Score of 19.9 ± 1.6) using the UPSIT. However, the same
authors employed the yes-no identification task and did not show
differences between MDD patients and controls. In the yes-no
identification task, odors were presented in similar quality pairs
(e.g., lemon and orange) and participants were asked to decide,
whether the presented odor matched a given verbal label. As
compared to the UPSIT, the yes-no identification task might be
easier to perform, requiring less cognitive resources. The authors
hypothesized that the differences between UPSIT and yes-no per-
formance in depressive patients may be a function of task-specific
difficulty, suggesting that the reduced identification performance
in MDD might be due to general deficits in cognitive demanding
tasks. Assessing odor identification performance by the Sniffin’
Sticks in a sample of MDD patients during a depressive episode
and in a remitted state, Clepce et al. (2010) showed a significant
reduced odor identification score only during the depressive state.
In line with Serby et al. (1992), Clepce et al. (2010) attributed the
poor identification performance in MDD patients to strong gen-
eral cognitive impairments. Zucco and Bollini (2011) investigated
olfactory identification and olfactory recognition performance in
patients with mild MDD and in patients with severe MDD as well
as in healthy controls. On the identification task, participants had
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Table 2 | Summary of studies of olfactory identification in affective disorders.
Study Number of
participants (f/m) and
diagnosis
Mean age ± SD Severity-scores Odors and test
method
Olfactory
identification
Amsterdam et al.,
1987
C: 51 (34/17)
P: 51 (34/17);
MDD/BPD II
C: /
P: m: 49 ± 14
f: 43 ± 13
P: 18 – 37 (HAM-D) UPSIT P = C
Clepce et al., 2010 C: 37 (21/16)
P: 37 (21/16);
MDD
C: /
P:
m: 48.31 ± 11.95
f: 47.52 ± 11.33
/ (BDI and SHAPS) Sniffin’ sticks P < C (acute MDD)
P = C (in remission)
Cumming et al., 2011 C: 22 (11/11)
P: 20 (10/10);
BPD
C: 35.5 ± 9.8
P: 34.6 ± 11.3
P: 16.3 ± 9.5 (BPRS)
9.9 ± 8.0 (YMRS)
12.0 ± 8.2 (HAM-D)
UPSIT BPD < C
Kopala et al., 1994 C: 77 (47/30)
P: 21 (13/8); MDD
C: 32.5 ± 11.1
P: 37.0 ± 9.6
/ UPSIT P = C
Krüger et al., 2006 BPD + ETE: 7 (1/6)
BPD – ETE: 9 (5/4)
BPD + ETE:
33.9 ± 10.7
BPD – ETE:
46.1 ± 11.6
BPD + ETE:
0.8 ± 1 (HAM-D)
0.8 ± 1.2 (SRMI)
BPD – ETE:
0.4 ± 0.7 (HAM-D)
1.4 ± 1 (SRMI)
Sniffin’ sticks BPD + ETE =
BPD – ETE
Lombion-Pouthier
et al., 2006
C: 58 (36/22)
P: 49 (35/14); MDD
C: 38.4 ± 13.96
P: 43.4 ± 17.54
P: 23.75 ± 5.74 (BDI) Test olfactif P = C
McCaffrey et al.,
2000
AD: 20 (13/7)
MDD: 20 (11/9)
AD: 74.15 ± 7.86
MDD: 67.55 ± 7.29
AD: 20.85 ± 5.22
(MMSE)
MDD: 28.6 ± 1.54
(MMSE)
Pocket smell test MDD > AD
Naudin et al., 2012 C: 54 (36/18)
P: 18 (12/16); MDD
C: 49.5 ± 12.5
P: 50.1 ± 13.3
C: 2.33 ± 2.3 (MADRS)
P (acute MDD):
35.1 ± 4.5
(MADRS)
P (clinically improved):
9.1 ± 5.6
(MADRS)
Identification of odors
(n = 8) from a list of
four descriptors
P(acute MDD) =
P(clinically
improved) = C
Negoias et al., 2010 C: 21 (15/6)
P: 21 (17/4);
MDD
C: 39.62 ± 11.39
P: 36.86 ± 10.13
P: 29.67 ± 10.84 (BDI) Sniffin’ sticks P = C
Oren et al., 1995 C: 21 (16/5)
P: 21 (16/5); SAD
C: 38 ± 9
P: 38 ± 9
P: 29 ± 6
(HAM-D,SAD-Version)
UPSIT P (SAD) = C
Pause et al., 2003 C: 22 (14/8)
P: 22 (14/8);
MDD
C: 48.4 ± 11.9
P: 47.2 ± 10
C: 3.6 ± 3.2 (BDI);
2.6 ± 3.5 (HAM-D)
P: 25.7 ± 9.4 (BDI),
21.8 ±8.9 (HAM-D)
PEA, isobutyraldehyde,
identification of odors
from a set of three
odors
P = C
Pentzek et al., 2007 C: 30 (24/6)
P: AD: 20 (15/5)
MDD 20 (15/5)
C: 77.07 ± 6.81
AD: 75.95 ± 9.09
MDD: 73.45 ± 5.61
C: 4.5 ± 3.34 (HAM-D),
8.83 ± 3.02 (ADAS-cog);
AD: 5.1 ± 4.72 (HAM-D),
25.05 ± 7.57 (ADAS-cog);
MDD: 19.05 ± 7.57
(HAM-D), 9.4 ± 3.22
(ADAS-cog)
Sniffin’ sticks A < C
A < MDD
MDD = C
(Continued)
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Table 2 | Continued
Study Number of
participants (f/m) and
diagnosis
Mean age ± SD Severity-scores Odors and test
method
Olfactory
identification
Postolache et al.,
1999
C: 24 (17/7)
P: 24 (17/7); SAD
C: 42.1 ± 11.8
P: 42.8 ± 9.7
/ UPSIT P = C
Serby et al., 1990,
1992
C: 9 (/)
P: 9 (0/9) MDD
C: 50 – 59
P: 50 – 59
P: 19.9 ± 1.6 (HAM-D) UPSIT;
Yes/No task
UPSIT: P < C
Yes/No task: P = C
Solomon et al., 1998 AD: 20 (12/8)
MDD: 20 (13/7)
AD: 74.5 ± 7.77
MDD: 69.4 ± 7.69
/ Pocket smell test MDD > AD
Swiecicki et al., 2009 C: 30 (20/10)
P: 46 (RDD:
20, BPD: 21)
C: 35.4 ± 2.1
RDD: 35.7 ± 2.3
BPD: 39.6 ± 2.5
C: 0.5 ± 0.3 (HAM-D),
1.9 ± 0.5 (BDI)
RDD: 15.2 ±
1.6 (HAM-D), 27.2 ± 2.8
(BDI);
BPD: 14.1 ± 1.0
(HAM-D), 23.2 ± 1.8
(BDI)
Sniffin’ sticks RDD = BPD = C
Warner et al., 1990 C: 8
P: 6;
MDD
C: 32 (20 – 44)
P: 37 (28 – 50)
/ UPSIT P = C
Zucco and Bollini,
2011
C: 12 (6/6)
P: 12 (6/6) Mild MDD;
12 (6/6) Severe MDD
C: 39.8 ± 7.1
P: Mild MDD: 41.3 ± 6.4
Severe MDD: 41.9 ± 6.2
/ Identification of odors
(n = 10) from a list of
four descriptors
Severe MDD <
Mild MDD = C
f, female; m, male; C, controls; P, patients; MDD, major depressive disorder; BPD II, bipolar disorder II; HAM-D, Hamilton Depression Rating-Scale; UPSIT, University
of Pennsylvania Smell Identification Test; =, no difference between groups; P < C: patients performed worse than controls; P > C patients performed better than
controls; BDI, Beck’s Depression Inventory; SHAPS, Snaith-Hamilton-pleasure-scale; BPRS, Brief Psychiatric Rating Scale; YMRS, Young Mania Rating Scale; BPD
+ ETE, bipolar disorder with event triggered episodes; BPD – ETE, bipolar disorder without event triggered episodes; SRMI, Self-Report Manic Inventory; AD,
Alzheimer’s dementia; MMSE, Mini-Mental State Exam; PEA, Phenyl-ethylalcohol; MADRS, Montgomery-Asberg Depression Rating Scale; SAD, seasonal Affective
Disorder;ADAS-cog, Alzheimer’s disease Assessment Scale; RDD, unipolar recurrent depressive disorder; BPD, bipolar disorder; /, no information available.
to smell an odor randomly selected from a set of 10 (aniseed,
cinnamon, coffee, garlic, ink, lavender, marsala liquor, mint,
petrol, and shoe-polish cream) and had to identify the correct
label for each odor (four-alternative-forced choice). The study
revealed significantly worse identification performance in the
severe MDD group compared to both the mild MDD group and
the healthy control group. In addition, olfactory identification
performance was significantly correlated with olfactory recogni-
tion performance. The authors concluded that the results indicate
the suitability of olfactory identification tasks for the assessment
of cognitive decline in MDD.
Few studies have examined olfactory identification perfor-
mance in other depressive disorders thanMDD. Oren et al. (1995)
examined the odor identification performance (UPSIT) in 21
medication-free patients with SAD, and found that the patients
scored as high as the 21 healthy controls. Postolache et al. (1999)
applied the UPSIT to 24 SAD patients and 24 matched controls.
Even though the UPSIT score did not significantly differ between
patients and controls, a negative correlation between the UPSIT
score and the score for typical depressive syndromes emerged in
depressed patients. This correlation was only observed for right
nostril stimulation, but not for left nostril stimulation.
Krüger et al. (2006) examined BPD patients with (n = 7) and
without (n = 9) event triggered episodes. Odor identification
performance was assessed by the Sniffin’ Sticks and no differences
between groups were observed. Swiecicki et al. (2009) investi-
gated olfactory identification performance in 21 BPD patients,
using the Sniffin’ Sticks, and found no olfactory alterations in the
patient group, as compared to healthy controls. A more recent
study with 20 BPD patients (without comorbidity; Cumming
et al., 2011) observed lower odor identification scores (UPSIT)
in BPD patients than in healthy controls. However, the olfactory
deficit in the BPD group was significantly less pronounced than in
a group of Schizophrenia patients. In this study, participants with
IQs < 75 were excluded (evaluated by the Wechsler abbreviated
scale of intelligence; Wechsler, 1999).
Summarizing odor identification performances in MDD
patients, most studies indicate that patients do not differ from
healthy controls. In line with this conclusion, MDD patients have
been found to perform significantly better on olfactory identi-
fication tasks than AD patients. Few studies reporting reduced
olfactory identification scores in MDD point to the possibility
that a general cognitive decline in severe depression affects higher
order odor processing, such as odor identification. As in MDD,
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odor identification deficits seem neither to be pronounced in SAD
nor in BPD.
Odor discrimination
To our knowledge, so far, only one study has investigated odor dis-
crimination ability in MDD patients (Table 3). Using the Sniffin’
Sticks Negoias et al. (2010) reported no differences in olfac-
tory discrimination performance between MDD patients and
healthy controls. The mean BDI-Score was 29.7 ± 10.8. Odor
discrimination performance in BPD was investigated by Krüger
et al. (2006). They reported that 7 BPD patients with an event-
triggered episode did not differ from 9BPD patients without
event-triggered episodes in their ability to discriminate odors.
ODOR RATINGS IN DEPRESSIVE DISORDERS
In the following, studies assessing the intensity, emotionality
(hedonic profile), and familiarity of odors in depressive disorders
will be reviewed.
Intensity ratings
Most studies observed intensity ratings of odors not to be altered
with MDD (Table 4). In a study by Pause et al. (2001) medi-
catedMDDpatients (mean BDI-Score: 28.5± 11.4) gave intensity
ratings of ten odors using a 7-point scale ranging from 0 to 6.
Compared to 24 healthy controls (mean BDI-Score: 4.8 ± 2.5),
there were no differences of odor intensity ratings. After success-
ful treatment, 18 MDD patients (mean BDI-Score: 11.5 ± 7.1)
and 18 healthy controls were tested again and also showed no
differences in intensity ratings. In an unselected sample of 16
patients with an MDD-episode (no diagnosis of the disorder, the
episode was related to), Thomas et al. (2002) did not show any
differences of odor intensity evaluations compared to a control
sample of 24 participants. To obtain ratings of six odors an analog
scale was used, grading from 1 (minimal intensity) to 5 (maxi-
mal intensity). Testing 5 patients with a MDD-episode in stable
remission and 5 controls a second time, Thomas et al. (2002)
also reported no group differences. In a study by Pause et al.
(2003) 20 MDD patients (mean BDI-Score = 26.4 ± 9.3) and
20 healthy controls (mean BDI-Score = 3.2 ± 3.2) were asked
to judge the intensity of PEA and isobutyraldehyde (7-point scale
ranging from 0 to 6). No differences between patients and con-
trols were observed. Pause et al. (2005) examined odor intensity
ratings in 11 psychotropic non-medicated MDD patients (mean
BDI-Score: 17.7 ± 6.9) and 11 control participants. They used a
20 cm analog scale, ranging from not intense at all to extremely
intense, to observe the ratings of two odors (PEA and menthol).
Groups did not differ with respect to their odor intensity ratings.
In a sample of 49 MDD patients (mean BDI-Score: 23.8 ± 5.7),
Lombion-Pouthier et al. (2006) also observed similar intensity
ratings compared to 58 healthy individuals. Intensity analog scales
grading from 0 (low intensity) to 10 (high intensity) were used
in order to investigate ratings of 16 odors. Clepce et al. (2010)
also reported no differences of odor intensity estimations in 37
MDD patients and 37 healthy controls either in an acute MDD
or a remission state of MDD. By means of a 200mm visual ana-
log scale ranging from 0 (very low intensity) and 200 (very high
intensity) participants were asked to rate the intensity of the 16
Sniffin Sticks odors.
In studies by Atanasova et al. (2010) and Naudin et al. (2012)
participants’ task was to evaluate the intensity of a pleasant odor
and an unpleasant odor that were presented in three different con-
centrations. Vanillin and butyric acid (Atanasova et al., 2010) as
well as PEA and isovaleric acid (Naudin et al., 2012) were used
to evaluate the odor intensity, either by means of a magnitude
estimate method (Atanasova et al., 2010) or by a 10 cm analog
scale, labeled at each end (very low intensity/very high intensity;
Naudin et al., 2012). Both studies revealed that MDD patients
perceived the unpleasant odor as significantly more intense than
the control group. Furthermore, Atanasova et al. (2010) reported
the perception of the pleasant odor by the MDD patients as less
intense compared to the healthy individuals. After 6 weeks of
treatment, Naudin et al. (2012) observed similar odor intensity
ratings between MDD patients and healthy controls. It was sug-
gested that presented results might indicate an olfactory anhedo-
nia for pleasant odors and an olfactory alliesthesia for unpleasant
odors.
In one study, odor intensity ratings of MDD patients (mean
BDI score= 22.9± 9.0) were compared to odor intensity ratings
Table 3 | Summary of studies of olfactory discrimination in affective disorders.
Study Number of
participants (f/m)
and diagnosis
Mean age ± SD Severity-scores Odors and test
method
Olfactory
discrimination
Krüger et al., 2006 BPD + ETE: 7 (1/6)
BPD – ETE: 9 (5/4)
BPD + ETE:
33.9 ± 10.7
BPD – ETE:
46.1 ± 11.6
BPD + ETE:
0.8 ± 1 (HAM-D)
0.8 + 1.2 (SRMI)
BPD – ETE:
0.4 ± 0.7 (HAM-D)
1.4 ± 1 (SRMI)
Sniffin’ Sticks BPD + ETE =
BPD – ETE
Negoias et al., 2010 C: 21 (15/6)
P: 21 (17/4); MDD
C: 39.62 ± 11.39
P: 36.86 ± 10.13
P: 29.67 ± 10.84
(BDI)
Sniffin’ Sticks P = C
f, female; m, male; C, controls; P, patients; BPD + ETE, bipolar disorder with event triggered episodes; BPD – ETE, bipolar disorder without event triggered episodes;
HAM-D, Hamilton Depression Rating-Scale; SRMI: Self-Report Manic Inventory; =, no difference between groups; MDD, major depressive disorder; BDI, Beck’s
Depression Inventory.
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Table 4 | Summary of studies of odor intensity ratings in affective disorders.
Study Number of
participants (f/m) and
diagnosis
Mean age ± SD Severity-scores Odors and test
method
Olfactory intensity
rating
Atanasova et al.,
2010
C: 30 (12/18)
P: 30 (12/18);
MDD
C: 33.4 ± 9.9
P: 34.6 ±11.1
C: 2 ± 2.1 (MADRS)
P: 36.3 ± 6.3
(MADRS)
6 olfactory stimuli,
prepared from vanillin
(pleasant) and butyric
acid (unpleasant) in
different concentrations
magnitude estimate
method
Vanillin (three
concentrations)/pleasant:
P < C
Butyric acid (three con-
centrations)/unpleasant:
P > C
Clepce et al., 2010 C: 37 (21/16)
P: 37 (21/16);
MDD
C: /
P:
m: 48.31 ± 11.95
f: 47.52 ± 11.33
/: (BDI and SHAPS) 16 odors of the sniffin’
sticks, visual analog
scale
P = C (in acute MDD and
in remission)
Lombion-Pouthier
et al., 2006
C: 58 (36/22)
P: 49 (35/14);
MDD
C: 38.4 ± 13.96
P: 43.4 ± 17.54
P: 23.75 ± 5.74 (BDI) Test olfactif;
rating scale
P = C
Naudin et al., 2012 C: 54 (36/18)
P: 18 (12/16);
MDD
C: 49.5 ± 12.5
P: 50.1 ± 13.3
C: 2.33 ± 2.3
(MADRS)
P (acute MDD):
35.1 ± 4.5
(MADRS)
P (clinically
improved):
9.1 ± 5.6
(MADRS)
Isovaleric acid, PEA;
rating scale
2-phenylethanol: acute
MDD = clinically
improved = C
Isovaleric acid: acute
MDD > C;
clinically improved = C
Pause et al., 2001 1. Session:
C: 24 (15/9)
P: 24 (15/9);
MDD
2. Session:
C: 18 (13/5)
P: 18 (13/5);
MDD in remission
C: 44.2 ± 12.6
P: 48.4 ± 13.2
C: 46.6 ± 12.8
P: 47.9 ± 13.4
C: 4.8 ± 2.5 (BDI)
P: 28.5 ± 11.4 (BDI)
C: 4.6 ± 3.4 (BDI)
P: 11.5 ± 7.1 (BDI)
10 odors;
rating scale
10 odors;
rating scale
P = C
P = C
Pause et al., 2003 C: 22 (14/8)
P: 22 (14/8);
MDD
C: 48.4 ± 11.9
P: 47.2 ± 10
C: 3.6 ± 3.2 (BDI),
2.6 ± 3.5 (HAM-D)
P: 25.7 ± 9.4 (BDI),
21.8 ±8.9 (HAM-D)
PEA, isobutyraldehyde,
linear scale
P = C
Pause et al., 2005 C: 11 (6/5)
P: 11 (7/4);
MDD (drug-free)
C: 33.0 ± 8.6
P: 32.7 ± 5.5
C: 2.1 ± 2.3 (BDI)
P: 17.7 ± 6.9 (BDI)
PEA, menthol;
visual analog scale
P = C
Pause et al., 2008 MDD: 9 (0/9)
SZ: 9 (0/9)
MDD: 55.1 ± 4.5
SZ: 33.4 ± 7.9
SZ: 31.9 ± 7.1 (BPRS)
MDD: 22.9 ± 9
(BDI);
40.3 ± 16.4 (HAM-D)
PEA, isobutyraldehyde,
linear scale
SZ =MDD
Thomas et al., 2002 C: 24
P: 16
(unselected depressed
with major depressive
episode)
/ 23.8 ± 9.5 (BDI) 8 odors, rating scale P = C
f, female; m, male; C, controls; P, patients; MDD, major depressive disorder; MADRS, Montgomery-Asberg Depression Rating Scale; SHAPS, Snaith-Hamilton-
pleasure-scale; PEA, phenyl-ethylalcohol; P < C, patients rated odors less intense; P > C patients rated odors more intense; =, no difference between groups; BDI,
Beck’s Depression Inventory; SZ, Schizophrenia patients; BPRS, Brief Psychiatric Rating Scale; /, no information available.
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of schizophrenia patients (range of intensity ratings: 0 to 6; Pause
et al., 2008). Intensity ratings did not differ between patient
groups.
In summary, the results of most studies regarding odor inten-
sity ratings in MDD showed evaluations of odor intensity to
be unaffected by MDD. However, intensity ratings for highly
pleasant or unpleasant odors might be changed in patients expe-
riencing major depressive episodes.
Hedonic ratings
In a study by Pause et al. (2001) valence ratings of ten odors were
investigated in MDD patients in an acute state of MDD (mean
BDI score: 28.5 ± 11.4) and in a remission state after successful
medical treatment (mean BDI score: 11.5 ± 7.1; see Table 5 for
a summary of results regarding hedonic ratings). To assess rat-
ings of odor pleasantness a 7-point scale ranging from −3 to +3
was used. Valence ratings of nine out of the ten odors were sim-
ilar in acute state MDD patients and healthy controls. However,
citral was perceived as significantly more pleasant by depressive
patients. After medical treatment, MDDpatients and healthy con-
trols gave similar ratings to all odors. As citral has been discussed
to have relaxing and anti-depressant properties, the authors sug-
gested that citral might be perceived as more distinct by depressed
patients than by healthy controls. The finding that MDD patients
rated the hedonic tone of odors similarly to healthy controls was
confirmed in three other studies: Assessing perceived odor pleas-
antness of seven odors in a sample of unselected MDD patients
in an acute state and in a stable remission state, Thomas et al.
(2002) also reported no differences between the patients’ group
and the control group. In order to assess hedonic evaluations ana-
log scales were used ranging from−5 (maximal unpleasant) to+5
(maximal pleasant). Pause et al. (2003) asked 20 MDD patients
(mean BDI-Score = 26.4 ± 9.3) and 20 healthy controls (mean
BDI-Score = 3.2 ± 3.2) to judge the emotional valence of PEA
and isobutyraldehyde (7-point scale: −3 to +3). It was shown
that the hedonic judgments were similar in patients and con-
trols. Swiecicki et al. (2009) reported that MDD patients (mean
BDI score: 27.2 ± 2.8, mean HAM-D score: 15.2 ± 1.5) evalu-
ated the pleasantness of 16 odors similar to healthy participants.
The participants’ task was to rate each odor of the Sniffin’ Sticks
identification test as pleasant, unpleasant or neutral.
Similiar to the finding that certain odors (like citral; Pause
et al., 2001) may be perceived as more pleasant in MDD patients,
Lombion-Pouthier et al. (2006) observed that MDD patients
(mean BDI score: 23.75 ± 5.7) evaluated pleasant odors as more
pleasant than healthy individuals. Participants gave ratings of
13 pleasant odors using analog scales graduated from 0 (dis-
pleasure) to 10 (pleasure). Another study by Pause et al. (2005)
found that drug free MDD patients (mean BDI score: 17.7± 6.9)
were inclined (p < 0.10) to rate odors (PEA and menthol) as less
unpleasant than healthy controls (mean BDI score: 2.1± 2.3).
However, other studies found depressive patients to rather
evaluate odors as more unpleasantness than more pleasant, sug-
gesting that the occurrence of anhedonia in MDD might affect
hedonic ratings. Clepce et al. (2010) assessed BDI-Scores as well
as Snaith-Hamilton-Pleasure-Scale (SHAPS; Franz et al., 2005)
scores. MDD patients (acute and remitted state) and healthy
controls rated the pleasantness of the 16 odors of the Sniffin’
Sticks using 200mm visual analog scales ranging from −100
(unpleasantness) to +100 (pleasantness). The study revealed a
significant correlation between anhedonia and hedonic estimates
during the acute episode of MDD, demonstrating that high
depression scores are related to low hedonic estimates of odors.
Atanasova et al. (2010) examined hedonic odor ratings
in MDD patients with a mean score of 36.3 ± 6.3 on
the Montgomery-Asberg Depression rating scale (MADRS;
Montgomery and Asberg, 1979). On a 10 cm analog scale (highly
unpleasant/highly pleasant) participants were asked to rate the
perceived pleasantness of vanillin (representing a pleasant odor),
and butyric acid (representing an unpleasant odor), and binary
mixtures of both odors, all in three different concentrations.
The study revealed that depressed patients perceived unpleasant
odors as significantly more unpleasant than controls. Atanasova
et al. interpreted this result as an indicator for olfactory negative
alliesthesia in MDD.
Naudin et al. (2012) aimed at determining whether olfac-
tory impairments are state or trait markers of a major depressive
episode. They evaluated depressed patients during acute episodes
of depression (mean MADRS = 35.1 ± 4.5) and 6 weeks after
antidepressant treatment (mean MADRS = 9.1 ± 5.6) against
healthy controls (mean MADRS = 2.3 ± 2.3). Hedonic ratings
of eight odors (four unpleasant odors, four pleasant odors) were
assessed using a 10 cm analog scale (highly unpleasant/highly
pleasant). During their acute phase, MDD patients rated five out
of the eight odors as less pleasant as controls. The deviant pleas-
antness ratings were rather observed for pleasant and unpleasant
odors than for neutral odors. However, after initiation of psychi-
atric treatment, only two out of eight odors were still judged as
less pleasant by depressive patients.
There are only a few studies available that contrast odor hedo-
nics in MDD patients to another psychiatric population. Pause
et al. (2008) found no differences in odor valence ratings between
MDD patients (mean BDI score: 22.9 ± 9.0; mean HAM-D
score: 40.3 ± 16.4) and schizophrenia patients. In this study,
valence ratings (7-point scale: −3 to +3) were obtained for PEA
and isobutyraldehyde. Swiecicki et al. (2009) reported that MDD
patients (mean BDI score: 27.2± 2.8, meanHAM-D score: 15.2±
1.5) rated fewer olfactory stimuli as pleasant compared to a BPD
group (mean BDI score: 23.2 ± 1.8, mean HAM-D score: 14.1
± 1.0). Participants were to rate each of the 16 odors of the
Sniffin’ Sticks identification test as pleasant, unpleasant or neu-
tral. Similar to the outcome that BPD patients seem to judge odors
as more pleasant than a comparable patient group, Cumming
et al. (2011) found that patients with BPD rated odors (40 odors
corresponding to the UPSIT items) as significantly more pleas-
ant than healthy controls. The ratings were judged on a five-point
scale (−2 to+2).
In conclusion, odor hedonics are not consistently changed in
depressive patients (Table 5). Two studies point to the possibil-
ity that MDD patients judge certain odors to be more pleasant
than healthy controls (Pause et al., 2001; Lombion-Pouthier et al.,
2006). However, the majority of studies found MDD patients
to judge the emotional valence of odors either in a normal
range or as less positive than healthy controls. This effect has
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Table 5 | Summary of studies of hedonic odor ratings in affective disorders.
Study Number of participants
(f/m) and diagnosis
Mean age ± SD Severity-scores Odors and test
method
Hedonic odor rating
Atanasova et al.,
2010
C: 30 (12/18)
P: 30 (12/18);
MDD
C: 33.4 ± 9.9
P: 34.6 ±11.1
C: 2 ± 2.1 (MADRS)
P: 36.3 ± 6.3 (MADRS)
15 olfactory stimuli,
prepared from
vanillin (pleasant) and
butyric acid
(unpleasant) in
different
concentrations and
their mixtures;
linear scale
Patients rated
unpleasant odors as
significantly more
unpleasant than
controls;
9 out of 15 stimuli
were rated as less
pleasant by patients
Clepce et al., 2010 C: 37 (21/16)
P: 37 (21/16);
MDD
C: /
P:
m: 48.31 ± 11.95
f: 47.52 ± 11.33
/: (BDI and SHAPS) 16 odors of the
sniffin’ sticks, visual
analog scale
P = C (in acute MDD
and in remission);
significant
interrelation
between anhedonia
and hedonic
estimates during an
acute MDD episode
Cumming et al., 2011 C: 22 (11/11)
P: 20 (10/10) BPD
C: 35.5 ± 9.8
P: 34.6 ± 11.3
C: /
P: 16.3 ± 9.5 (BPRS)
9.9 ± 8.0 (YMRS)
12.0 ± 8.2 (HAM-D)
Odors of the UPSIT;
likert like scale
BPD patients rated
odors as more
pleasant than
controls
Lombion-Pouthier
et al., 2006
C: 58 (36/22)
P: 49 (35/14);
MDD
C: 38.4 ± 13.96
P: 43.4 ± 17.54
P: 23.75 ± 5.74 (BDI) Test olfactif;
rating scale
Patients
over-evaluate the
pleasantness of
pleasant odors
Naudin et al., 2012 C: 54 (36/18)
P: 18 (12/16);
MDD
C: 49.5 ± 12.5
P: 50.1 ± 13.3
C: 2.33 ± 2.3
(MADRS)
P (acute MDD):
35.1 ± 4.5
(MADRS)
P (clinically improved):
9.1 ± 5.6
(MADRS)
8 odors, linear scale Acute MDD: P rated
5 odors as less
pleasant, Clinically
improved: two odors
were rated to be less
pleasant by the
patients
Pause et al., 2001 1. Session:
C: 24 (15/9)
P: 24 (15/9);
MDD
2. Session:
C: 18 (13/5)
P: 18 (13/5);
MDD in remission
C: 44.2 ± 12.6
P: 48.4 ± 13.2
C: 46.6 ± 12.8
P: 47.9 ± 13.4
C: 4.8 ± 2.5 (BDI)
P: 28.5 ± 11.4 (BDI)
C: 4.6 ± 3.4 (BDI)
P: 11.5 ± 7.1 (BDI)
10 odors;
rating scale
10 odors;
rating scale
9 odors:P = C;
citral was rated to be
more pleasant by the
patients
P = C
Pause et al., 2003 C: 22 (14/8)
P: 22 (14/8);
MDD
C: 48.4 ± 11.9
P: 47.2 ± 10
C: 3.6 ± 3.2 (BDI);
2.6 ± 3.5 (HAM-D)
P: 25.7 ± 9.4 (BDI),
21.8 ± 8.9 (HAM-D)
PEA,
isobutyraldehyde,
linear scale
P = C
Pause et al., 2005 C: 11 (6/5)
P: 11 (7/4);
MDD (drug-free)
C: 33.0 ± 8.6
P: 32.7 ± 5.5
C: 2.1 ± 2.3 (BDI)
P: 17.7 ± 6.9 (BDI)
PEA, menthol;
visual analog scale
Patients tended
(p < 0.1) to rate
odors as less
unpleasant than
controls
(Continued)
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Table 5 | Continued
Study Number of participants
(f/m) and diagnosis
Mean age ± SD Severity-scores Odors and test
method
Hedonic odor rating
Pause et al., 2008 MDD: 9 (0/9)
SZ: 9 (0/9)
MDD: 55.1 ± 4.5
SZ: 33.4 ± 7.9
SZ: 31.9 ± 7.1 (BPRS)
MDD: 22.9 ± 9 (BDI);
40.3 ± 16.4 (HAM-D)
PEA,
isobutyraldehyde,
linear scale
SZ =MDD
Swiecicki et al., 2009 C: 30 (20/10)
P: 46
(RDD: 20, BPD: 21)
C: 35.4 ± 2.1
RDD: 35.7 ± 2.3,
BPD: 39.6 ± 2.5
C: 0.5 ± 0.3 (HAM-D),
1.9 ± 0.5 (BDI);
RDD: 15.2 ± 1.6
(HAM-D), 27.2 ± 2.8
(BDI);
BPD: 14.1 ± 1.0
(HAM-D), 23.2 ± 1.8
(BDI)
Odors of the sniffin’
sticks
RDD and BPD = C;
RDD patients rated
less olfactory stimuli
as pleasant as
compared to BPD
patients
Thomas et al., 2002 C: 24
P: 16
(unselected depressed
with major depressive
episode)
/ 23.8 ± 9.5 (BDI) 8 odors, rating scale P = C
f, female; m, male; C, controls; P, patients; MDD, major depressive disorder; MADRS: Montgomery asberg depression rating scale; BDI: Beck’s depression inventory;
SHAPS, Snaith-Hamilton-pleasure-scale; BPD: bipolar disorder; BPRS, Brief Psychiatric Rating Scale; YMRS, Young Mania Rating Scale; HAM-D: Hamilton depression
scale; =, no difference between groups; UPSIT, University of Pennsylvania Smell Identification Test; PEA, phenyl-ethylalcohol; SZ, Schizophrenia; RDD, recurrent
depressive disorder; /, no information available.
been observed for standard test odors and especially for emo-
tionally negative odors (Atanasova et al., 2010). The hypothesis
that depressive patients perceive the hedonic profile of emotion-
ally negative odors as more intense than healthy individuals is
supported by the finding that MDD patients report a higher
physiological arousal in response to emotionally negative odors
than healthy controls (Pause et al., 2000). The findings in MDD
patients cannot be generalized to BPD patients, who seem to
perceive odors as more pleasant than healthy controls.
Familiarity ratings
To our knowledge, there are only four studies concerning ratings
of odor familiarity in MDD patients (Table 6). There are no stud-
ies with respect to familiarity ratings in BPD or SAD. Thomas
et al. (2002) found slight differences between a sample of 16 uns-
elected patients suffering from an acute MDD-episode without
comorbidity and 24 healthy controls. Familiarity ratings of odors
(dried fish, parmesan cheese, gyran, alpha-methylnaphtylketone,
coffee, and vanilla) were assessed by means of visual analog
scales ranging from −5 (most unfamiliar) to +5 (most famil-
iar). Depressed patients tended to rate vanilla (p = 0.051) and
dried fish (p = 0.099) to be less common than healthy controls.
Five MDD patients in a stable remission state of MDD were
retested. Compared to 5 retested controls, patients rated odor
familiarity in a similar way. Pause et al. (2005) examined 11
antidepressant drug-free MDD patients (mean BDI-Score: 17.7
± 6.9) and 11 controls (mean-BDI-Score: 2.1 ± 2.3). To assess
odor familiarity ratings, they used visual analog scales (anchor:
familiar—unfamiliar) and presented PEA and menthol as odors.
Groups did not differ in familiarity ratings of either PEA or
menthol. Atanasova et al. (2010) assessed odor familiarity rat-
ings in 30 MDD patients (mean MADRS-Score: 36.3 ± 6.3) and
30 healthy controls. They used a 10 cm analog scale, labeled at
each end (unfamiliar odor and very unfamiliar odor), for ratings
of vanillin and butyric acid. They found no differences between
groups for either odor in familiarity evaluations. Naudin et al.
(2012) examined odor familiarity ratings in 18MDD patients and
a control group (n = 54). They used analog scales for the ratings
and assessed ratings again after MDD patients in remission. For
all odors, except vanillin, the authors reported no group differ-
ences in odor familiarity ratings. Vanillin was evaluated as less
familiar by MDD patients and patients in remission as compared
to healthy controls.
In sum, ratings of odor familiarity do not seem to be strongly
altered in MDD.
AFFECTIVE REACTIONS TO OLFACTORY STIMULI IN MDD
Only two studies investigated emotional reactivity or affective
states after odor exposure. Steiner et al. (1993) investigated
valence ratings and facial expressive features (assessed by observer
ratings with regard to the quality, strength and duration of facial
expressions) in 21MDDpatients as an indicator for affective reac-
tions to olfactory stimuli (rose oil and amyl acetate representing
pleasant odors and butyric acid and methyl mercaptan represent-
ing unpleasant stimuli). The patient sample was found to display
reduced facial expressions while presenting pleasant odors and
to show reduced durations of facial expressions in response to
either pleasant or unpleasant odors. That was contrary to the
valence ratings that did not differ between patients and healthy
controls.
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In another study by Pause et al. (2000), affective reactions to
olfactory and visual stimuli (emotional scenes) were assessed in
26 MDD patients (mean BDI-Score: 29.4 ± 11.4) and 26 healthy
controls (mean BDI-Score: 4.7 ± 2.5). Participants were to
describe their emotional reaction to 10 odors (pleasant, unpleas-
ant and neutral) and 20 pictures on three dimensions (valence,
arousal, and dominance) by means of the self-assessment-
manikin (Bradley and Lang, 1994). The study revealed higher
arousal in MDD patients while presenting negative stimuli for all
stimulus modalities.
In sum, both studies indicate that emotional reactions to odors
are altered in MDD patients, irrespective of odor evaluation
strategies. However, elevated affective reactions to emotionally
negative odors do not seem to be modality-specific.
PSYCHOPHYSIOLOGY AND NEUROANATOMY OF OLFACTION IN MDD
The data presented in the previous section indicate that olfactory
sensitivity is reduced in depressed patients. Therefore, and fol-
lowing the annotations by Martzke et al. (1997), odor perception
in depression seems to be altered on an early sensory process-
ing level. Other perceptual performances, like odor identification
and discrimination, do not seem to be strongly altered in MDD
patients, indicating that the cognitive-evaluative level of olfactory
processing is not impaired in depression.
By means of event-related potential (ERP) analysis, Pause et al.
(2003) investigated olfactory, visual, and emotional stimulus pro-
cessing in MDD patients and in healthy controls. Patients were
examined at the beginning of their therapy and after success-
ful medical treatment. Pause and colleagues focused on whether
olfactory function in depression is disturbed in a modality-
specific manner. Within the ERP, early and late potentials were
analyzed. While early potentials, such as the P2, are related to
early pre-attentive stimulus encoding, late potentials, such as the
P3 and the late positive Slow Wave (pSW), are rather related to
late evaluative stimulus processing. The study revealed that MDD
patients responded to odors with reduced early (P2) and late
(P3-1) potential amplitudes. In response to colors, and emotional
slides they showed reduced late potential amplitudes only (colors:
P3 and pSW; emotional slides: pSW). After successful psychi-
atric treatment, the event-related potentials to either stimuli did
not differ between groups. The authors discuss the reduction
of the early potential amplitudes of the chemosensory ERP in
Table 6 | Summary of studies of odor familiarity ratings in affective disorders.
Study Number of participants
(f/m) and diagnosis
Mean age ± SD Severity-scores Odors and test
method
Odor familiarity
rating
Atanasova et al.,
2010
C: 30 (12/18)
P: 30 (12/18);
MDD
C: 33.4 ± 9.9
P: 34.6 ±11.1
C: 2 ± 2.1 (MADRS)
P: 36.3 ± 6.3 (MADRS)
15 olfactory stimuli,
prepared from
vanillin (pleasant) and
butyric acid
(unpleasant) in
different
concentrations and
their mixtures;
linear scale
Vanillin and butyric
acid: P = C
Naudin et al., 2012 C: 54 (36/18)
P: 18 (12/16);
MDD
C: 49.5 ± 12.5
P: 50.1 ± 13.3
C: 2.33 ± 2.3
(MADRS)
P (acute MDD):
35.1 ± 4.5
(MADRS)
P (clinically improved):
9.1 ± 5.6
(MADRS)
8 odors 7 odors:
P = C;
vanillin: P < C
Pause et al., 2005 C: 11 (6/5)
P: 11 (7/4);
MDD (drug-free)
C: 33.0 ± 8.6
P: 32.7 ± 5.5
C: 2.1 ± 2.3 (BDI);
P: 17.7 ± 6.9 (BDI)
PEA, menthol;
visual analog scale
P = C
Thomas et al., 2002 C: 24
P: 16
(unselected depressed
with major depressive
episode) and 5 retested
patients in stable
remission
/ 23.8 ± 9.5 (BDI) 8 odors, rating scale Vanilla: P < C,
(p = 0.051);
dried fish: P < C
(p = 0.099);
patients in stable
remission = C
f, female; m, male; C, controls; P, patients; MDD, major depressive disorder; MADRS, Montgomery-Asberg Depression Rating Scale; PEA, phenyl-ethylalcohol; =,
no difference between groups; P < C, patients rated odors less intense; BDI, Beck’s Depression Inventory; /, no information available.
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MDD patients to reflect a modality-specific reduction in the abil-
ity to encode basic olfactory information on an early level of
sensory processing. This interpretation is in line with the data
demonstrating a reduced olfactory sensitivity in MDD patients.
However, the reduction of the late positive potentials in response
to colored and emotional slides might have been related to the
non-modality specific effect of a reduced late evaluative stimulus
processing in MDD patients.
In another ERP study, Pause et al. (2008) contrasted olfac-
tory and visual stimulus (colored slides) processing in 9 MDD
patients and 9 Schizophrenia patients (all males). In response to
odors (PEA and isobutyraldahyde), MDD patients showed longer
latencies of all ERP components than Schizophrenia patients.
Additionally, the amplitude of the pSW in response to colors was
larger in MDD patients than in Schizophrenia patients. These
results indicate that the reduced olfactory processing capacities
(as shown in longer latencies or reduced amplitudes) in MDD
patients are modality-specific and prominent in comparison to
healthy individuals and also in comparison to other psychiatric
patient groups.
Negoias et al. (2010) assessed olfactory function and the vol-
ume of the olfactory bulb (OB) in patients with acute MDD.
Participants underwent measures of odor threshold, discrimina-
tion and identification using the Sniffin’ Sticks test battery in a
lateralized fashion. OB volumes were calculated by manual seg-
mentation of acquired T2-weighted coronal slices according to a
standardized protocol. The study revealed that MDD patients had
a significantly lower olfactory sensitivity and smaller OB volumes
as compared to healthy controls. There were no group differences
for olfactory discrimination and identification scores. A signifi-
cant correlation between OB volumes and odor thresholds was
observed for the left nostril: the lower the olfactory sensitivity, the
smaller the OB volume. Additionally, Negoias et al. (2010) found
a significant negative correlation between olfactory bulb volume
and depression scores (BDI).
In sum, the data indicate that olfactory stimulus process-
ing is altered on an early sensory processing level in patients
with acute severe MDD. This olfactory dysfunction seems to be
modality- and disorder-specific. Furthermore, the reduced capac-
ity to encode olfactory information in MDD seems to be accom-
panied by higher olfactory thresholds and smaller OB volumes.
Whether or not olfaction is impaired on the later cognitive-
evaluative level seems to depend on the progress of general
cognitive decline during depressive episodes, but seems not to be
depend on the stimulus modality.
OLFACTORY PERFORMANCE IN HEALTHY INDIVIDUALS WITH
DEPRESSIVE SYMPTOMS
In the following section, studies will be outlined, which investi-
gated healthy individuals scoring high on some depressive symp-
toms but not fulfilling the diagnostic criteria for MDD or any
other psychiatric disorder.
Satoh et al. (1996) examined odor ratings in Japanese elderly
participants (mean age inmen: 73.2± 6.0; in women: 72.4± 5.9).
Odor ratings were obtained for the 40 odor items of the UPSIT.
As a main result, it was found that elderly men with increased
depression scores (assessed by the self-rating depression scale;
Zung, 1965) rated odors to be weaker than their non-depressive
counterparts.
In another study (Economou, 2003) smell identification per-
formance (UPSIT) was investigated in elderly Greek people,
ranging in age from 49 to 88 years. Correlations between the
UPSIT and the BDI-II score were not significant, suggesting
that in elderly healthy individuals, a small number of depressive
symptoms does not affect odor identification.
Olfactory discrimination scores were assessed in young adults
(mean age: 19.3 ± 1.6) by Goel and Grasso (2004). The olfactory
discrimination test included 7 items and was based on five dif-
ferent blends of commercially available lavender oil. Participants
were to indicate, whether a certain blend was the same, stronger,
or weaker than another blend, briefly presented before. All par-
ticipants rated their depressive symptoms on the BDI man-
ual. Whereas overall olfactory performance was not related to
the BDI score, participants with higher BDI scores solved two
out of the seven items better than participants with a lower
BDI score.
Pollatos et al. (2007a) examined 48 participants who reported
a small number of depressive symptoms (BDI score < 10).
Olfactory sensitivity and discrimination performance were
assessed by means of Sniffin’ Sticks (odor for the threshold
test: n-butanol). Concerning olfactory sensitivity, the degree of
depressive symptoms was inversely correlated to the olfactory
threshold score: The higher the number of depressive symptoms
the lower the olfactory sensitivity. However, olfactory discrimi-
nation performance was not related to the degree of depressive
symptoms. These results correspond to data of studies concerning
olfactory sensitivity in patients with MDD that reported elevated
thresholds in MDD patients.
Pouliot et al. (2008) investigated the relation between olfactory
perception (odor detection, identification and ratings of odor
pleasantness and intensity) in 32 healthy menopausal women.
Anhedonia, one symptom frequently occurring in MDD, was
assessed by the Physical Anhedonia Scale (Chapman et al., 1976).
Women below or equaling the median anhedonia score of 14 were
classified as low-anhedonic and women with a higher anhedo-
nia score than 14 were assigned to the high-anhedonia group.
Participants underwent the European test of olfactory capabil-
ities (ETOC; Thomas-Danguin et al., 2003). The test consists
of an odor detection task and an odor identification task using
a panel of 16 odors. Firstly, Participants are asked to detect
the odor bottle out of four bottles (three bottles that are not
holding any odor) and, secondly, to identify the detected odor
by choosing a label out of four given labels. Olfactory perfor-
mances of detection (an indicator of olfactory sensitivity) and
identification are integrated in one olfactory performance score.
Additionally, in the study by Pouliot et al. (2008) pleasantness
and intensity of the ETOC-odors were rated by the partici-
pants on a 9 point scale. Pouliot et al. (2008) reported that
high-anhedonic menopausal women had a worse olfactory func-
tion than women with a lower anhedonia score. Women in
the low anhedonia group rated more odors as pleasant and as
neutral than as unpleasant. Moreover, it was observed that the
anhedonia score correlated negatively with the perceived odor
pleasantness.
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Conflicting results were obtained in a study conducted by
Scinska et al. (2008). In a sample of non-clinical older adults
(mean age: 63.0± 1.1), the relation between depressive symptoms
and olfactory performance (odor detection thresholds and odor
identification ability) was investigated. Depression scores were
assessed by the Geriatric Depression Scale (GDS; Yesavage, 1988).
Depending on the GDS-Score, participants were classified as
depressed (GDS-Score > 5) or as non-depressed (GDS-Score <
5). In order to assess olfactory performance, Sniffin’ Sticks were
used and the odor for the threshold test was n-butanol. The study
revealed that depressive symptoms were not related to any mea-
surement of olfactory performance. However, the authors found
that age was significantly correlated with both olfactory measures;
as expected older participants performed worse on the olfactory
tests.
In sum, three out of six studies (Satoh et al., 1996; Pollatos
et al., 2007a; Pouliot et al., 2008) reveal that the experience
of depressive symptoms in healthy individuals affects olfactory
performances. All of these studies found scores of odor sen-
sitivity (as assessed by intensity ratings, odor detection per-
formances and threshold tests) to be reduced in individu-
als with depressive symptoms. However, two studies investi-
gated odor perception (identification and sensitivity) in older
adults and failed to establish a relation between olfaction and
depression scores (Economou, 2003; Scinska et al., 2008). As
olfactory functions have been repeatedly reported to decline
with age (e.g., Doty et al., 1984a; Hummel et al., 2007), in
these two studies, effects of age might have overshadowed
effects of depression, resulting in overall low olfactory per-
formances, which are unlikely to be further reduced by psy-
chiatric symptoms. In addition, one study (Goel and Grasso,
2004) indicated that olfactory discrimination performance for
certain odors might even be increased during depressive mood
states.
OLFACTORY PERFORMANCE IN HEALTHY INDIVIDUALS WITH
TRANSIENTLY EXPERIENCED DEPRESSION-LIKE FEELINGS
To our knowledge, there are only two studies investigating odor
perception in healthy participants who transiently experience
depression-like feelings.
Laudien et al. (2006) considered symptoms of learned helpless-
ness as a mood state similar to symptoms occurring in depression.
The term “helplessness” has been adopted to denote a negative
emotion, which is characterized by lack of control, significant
negative expectancies for the future and deterioration of cogni-
tive performance (e.g., Hiroto and Seligman, 1975). By means
of ERP analysis, olfactory and auditory stimulus processing was
investigated in healthy individuals who transiently experienced
helplessness or were in a neutral mood state. In order to induce
helplessness, participants were exposed to uncontrollable fail-
ure in an unsolvable face-classification task. Odors (PEA and
menthol) were presented by an olfactometer. While experienc-
ing helplessness, participants’ responses to odorous stimuli were
attenuated at an early processing stage: the amplitudes of P2 and
P3-1 were smaller and the latencies of N1, P2 and P3-1 were
longer. Effects were only shown for the olfactory modality and
not for the auditory modality. Results indicate that the CSERP
displays transient mood effects, resembling the CSERP effects in
MDD patients (Pause et al., 2003).
Pollatos et al. (2007b) investigated olfactory sensitivity and
olfactory discrimination ability by Sniffin’ Sticks (odor for the
threshold test: n-butanol) as well as perceived pleasantness and
intensity of n-butanol by a 9 point scale in 32 healthy partic-
ipants. Prior to the olfactory testing, participants underwent a
procedure of emotion induction by presenting pleasant, unpleas-
ant and neutral pictures from the IAPS (International Affective
Picture System; the center for the study of emotion and attention).
Results show that olfactory sensitivity was decreased after presen-
tation of unpleasant pictures, and only in male participants were
olfactory thresholds increased after viewing pleasant pictures as
well. Olfactory discrimination ability did not show any alterations
in dependence of the emotional state condition. The authors con-
cluded that negative emotional experience is accompanied by a
reduced olfactory sensitivity. They suggested that, in addition,
odor perception inmen is strongly interfered with arousing states.
The studies by Laudien et al. (2006) and Pollatos et al.
(2007b) show that even transient experiences of negative mood
or helplessness affect odor perception at a sensory level. As in
depressive patients, threshold values are increased during nega-
tive mood states, but tests involving cognitive performance, like
odor discrimination, are not affected by a transient mood decline
(Pollatos et al., 2007b).Moreover, as in depressive patients, central
nervous processing of odors in helpless individuals is attenuated
at an early processing stage, related to stimulus encoding, but
unchanged at a late processing stage, related to cognitive odor
evaluation.
DISCUSSION
METHODOLOGICAL CONSIDERATIONS ON OLFACTORY ASSESSMENT
AND THEIR IMPLICATIONS FOR STUDY DIFFERENCES
Obviously, measuring olfaction in patients with depressive dis-
orders needs to be reliable and valid. Thus, olfaction as well as
depression should be assessed with unambiguous measurements.
Measuring olfaction requires the standardization of context
variables inherently linked to the chemical senses. Temperature
and air humidity are factors that can alter the evaporation rate
of odors (Mozell et al., 1986) and should thus be controlled in
tests on olfactory performance. Most volatile chemicals stimu-
late the olfactory as well as the trigeminal nerve. Stimulating
the trigeminal nerve produces stinging, burning, tickling, warm,
or cold sensations. Regarding olfactory acuity, odors that only
stimulate the olfactory nerve (nervus olfactorius) should be used
in olfactory testing. Odors, for example n-butanol, which do
not exclusively stimulate the first cranial nerve (nervus olfacto-
rius), can also produce sensations in anosmic individuals. PEA
or vanillin may be more suitable in olfactory acuity assessment
because they seem to be nearly pure olfactory stimulants (Doty
et al., 1978). Further, it should be considered whether partici-
pants should take a natural sniff in the olfactory test procedure.
Berglund et al. (1986) and Laing (1983) showed that olfactory
threshold assessment using an external constant airflow pro-
duced more elevated thresholds than olfactory assessment with
natural sniffing. In addition, sniffing seems to be necessary for
the neuronal priming of odor processing within the olfactory
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bulb (Gerkin et al., 2013). Several procedures have been pub-
lished which have been used in the measurement of olfactory
performance (e.g., number of items, ascending or descending
stimulus presentation in threshold tests). These test characteris-
tics have been reviewed elsewhere (Doty, 2006, 2007). In general,
implementing a standard test procedure, comparable between
different studies, seems to be advantageous. Besides olfaction-
specific requirements, performance testing relies on general test
characteristics. For example, in olfactory testing the item diffi-
culty is rarely considered. However, in olfaction, easy items (tasks,
which are easy to solve in the general population) may be useful
in testing relatively strong deficits in elderly individuals or neu-
rologic or psychiatric patients, while difficult items (tasks, which
are difficult to solve in the general population) seem to be more
suitable in measuring performance differences in healthy young
individuals (Weierstall and Pause, 2012).
As already mentioned, functions of human olfaction can
be characterized as either primary (olfactory sensitivity) or
secondary (olfactory identification, discrimination or recogni-
tion). The distinction of human olfaction as either primary
or secondary indicates that one single test of olfactory perfor-
mance might not be a sufficient marker of olfactory functioning
(Martzke et al., 1997). However, olfactory sensitivity performance
can be altered by centrally mediated events known as top-down
processing, and furthermore, the interpretation of secondary
olfactory functions (e.g., identification or discrimination) is con-
tingent upon available data about the intactness of the primary
sensory systems (e.g., intact olfactory acuity). Many studies of
olfactory performance do not regard the necessity to obtain mea-
sures on primary and secondary olfactory functions in order to
judge olfactory abilities in patients.
Besides psychophysical test procedures, electrophysiological
measures, like CSERPs, are promising tools aiding to differen-
tiate primary from secondary odor processing. Research on the
relation between olfaction and depression, has demonstrated that
early sensory odor processing is attenuated in MDD patients
and in healthy individuals experiencing helplessness, while late
evaluative odor processing is not affected (or only affected in
a modality non-specific manner). These findings correspond to
studies showing that olfactory sensitivity is reduced in MDD
patients, while odor discrimination and odor identification often
remains unaffected.
Similar to the considerations on the tests of olfaction, also the
tests of depression need to be appropriate. Thus, in patient stud-
ies, it is required to assess the distinct type of depressive disorder
and the severity of the depressive symptoms. While most stud-
ies include measures of symptom severity (e.g., HAM-D, or BDI),
some studies lack a precise diagnosis of the depressive symptoms.
Major depressive episodes might occur in MDD, in BPD, in SAD
or mood disorders, which are due to other medical conditions
(e.g., multiple sclerosis, stroke, hypothyroidism). However, the
foregone summary reveals that there are disorder specific alter-
ations of olfactory perception. Therefore, in depression research,
it is a prerequisite to specify the differential diagnosis.
A general cognitive decline that occurs during a depressive
episode has been suggested to be the underlying process of
impaired olfactory identification ability showed by some studies
that examined MDD patients. However, cognitive impairments
should be considered in olfactory testing in general. For exam-
ple, memory, attention, executive functions, or language deficits
can affect olfactory identification or discrimination performance.
The amount of influence by these factors is partly task-dependent:
whereas olfactory discrimination tests vary with the amount of
attentional resources and working memory performance, olfac-
tory identification tasks, vary with language skills, semantic mem-
ory, and executive functions (Doty and Laing, 2003; Schubert
et al., 2013; Zucco et al., 2014). Furthermore, the familiarity of an
odor can lead to increased discrimination performance (Rabin,
1988). However, olfactory sensitivity seems to be rather unaf-
fected by cognitive factors. According to Hedner et al. (2010) cog-
nitive factors like executive functioning, semantic memory, and
episodic memory are unrelated to odor threshold scores. Thus,
in order to make sure that alterations in olfactory perception
are directly related to the disorder (and it’s specific neurological
underpinnings) and not secondary to cognitive or motivational
deficits, appropriate control conditions need to be implemented.
Such control conditions should consist of cognitive tests (most
importantly assessing short-termmemory, and attentional capac-
ities) or control tests which assess perceptional performances in
other modalities than olfaction (Pause et al., 2003).
In summary, there are some methodological considerations
which should be taken into account in investigating olfactory per-
formance in depressive disorders. The considerations refer to the
kind of olfactory test, which might be most suitable and to the
precise measurement of the kind of depressive disorder. To con-
trol influences of cognitive or motivational factors on olfactory
performance (especially odor identification and odor discrimina-
tion), cognitive functioning should be evaluated. As summarized
above, the alterations in olfactory performances are specific to
the depressive disorder (e.g., MDD or BPD), therefore, direct
comparisons of sensory performances between and within psy-
chiatric populations are recommended (see e.g., Pentzek et al.,
2007; Pause et al., 2008).
GENERAL IMPLICATIONS
The literature on olfaction in depressive disorders and healthy
people experiencing a negative mood state has been summarized.
Regarding olfactory sensitivity in MDD, almost all studies show
elevated olfactory thresholds in patients as compared to healthy
controls. The olfactory impairments can be observed whether or
not patients are treated with antidepressants, indicating that the
reduced odor sensitivity is directly related to the depressive dis-
order. Furthermore, the sensitivity impairments disappear with
successful treatment of MDD. Accordingly, two studies reveal that
severity of MDD and reduced olfactory sensitivity are signifi-
cantly correlated. The decline in olfactory sensitivity seems to be
specific for MDD and has not been observed in BPD or SAD.
Olfactory identification ability in MDD was found to be unaf-
fected in most of the studies. However, some studies found
reduced odor identification performances in patients with severe
MDD. It is likely that the worse odor identification performance
in these MDD patients is due to a general cognitive deficit, which
accompanies severe depressive symptoms. Due to the limited evi-
dence, the degree of olfactory identification performance in BPD
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and SAD remains unclear. There is only one study (Negoias et al.,
2010) investigating discrimination ability in MDD, revealing no
differences between patients and control group.
Evaluations of odor characteristics are assessed with regard to
intensity, hedonic aspects or familiarity. Odor intensity ratings
seem to be unaffected by MDD. However, intensity ratings for
highly pleasant or unpleasant odors might be changed in MDD
patients. Most studies reveal the emotional valence of odors to be
rated in a normal range or as less positive in MDD patients as
compared to healthy participants. This is in line with the findings
that MDD patients report a higher arousal in response to emo-
tionally negative odors than healthy participants. In contrast to
MDD patients, BPD patients seem to judge odors as emotionally
more positive than healthy controls. Familiarity ratings seem not
to be altered in MDD.
Regarding the psychophysiology of olfaction, early potential
amplitudes of the CSERP in MDD patients are reduced in a
modality-specific manner. Further, regarding the neuroanatomy
of olfaction in MDD, patients showed smaller OB volumes com-
pared to healthy controls and reduced olfactory sensitivity was
negatively correlated with the OB volume. Both findings indi-
cate that odor perception in MDD is altered at an early sensory
processing level.
Similar to depressive patients, healthy individuals with depres-
sive symptoms as well as individuals experiencing a transient neg-
ative mood seem to show a reduced olfactory sensitivity, whereas
odor identification or discrimination appears to be unchanged.
In addition, early sensory odor processing, as indexed by CSERP
analysis is attenuated in MDD patients as well as in healthy
individuals experiencing helplessness. These findings indicate
that similar neurophysiological processes appear to modulate the
effects of negative mood or depression on the olfactory system.
Altogether, reviewed data show that odor perception in MDD
and healthy but sad individuals is altered on an early sensory
processing level. Alterations of olfaction on a later cognitive-
evaluative level seem to vary with the magnitude of a general
cognitive impairment during depressive episodes. These findings
have practical and theoretical implications: First, as even healthy
individuals experiencing sad mood show reduced olfactory per-
formances it is highly probable that alterations in odor perception
precede the manifestation of a depressive disorder. Therefore,
olfactory tests could be useful to be added to the early diagnosis
of depressive symptoms during the development of a depressive
disorder. Furthermore, as the reduced olfactory performance in
MDD patients seems to be disorder-, modality-, and test-specific,
the application of an appropriate olfactory and cognitive test-
battery might be highly useful in the differential diagnosis of
MDD (as compared to other disorders which also include the
manifestation of depressive episodes).
Second, it is likely that structures of the primary olfactory cor-
tex are affected during depressive experiences. Primary cortical
processing structures of the olfactory system are the OB and its
direct project areas (the anterior olfactory nucleus, the piriform
cortex, the anterior cortical nucleus of the amygdala, the peri-
amygdaloid cortex and the anteromediate part of the entorhinal
cortex). The amygdala, especially the anterior cortical nucleus,
receives direct information from the OB (see Carmichael and
Price, 1994; Cleland and Linster, 2003).
Rats with excised OBs (OB rats) are proposed to be an animal
model of depression. It is observed that OB rats show behav-
ioral, neurotransmitter, immune and endocrine changes similar
to patients with depression. Additionally, behavioral changes in
the OB rat can be treated by antidepressants given chronically
(Richardson, 1991). Regarding behavioral changes, OB rats show
increased locomotor activity in a novel environment, impaired
spatial learning and taste aversion learning. In addition, they show
increased reactivity to stressors, which is related to higher levels
of adrenocorticotrophic hormone (see Kelly et al., 1997; Harkin
et al., 2003). The alterations of the physiology and behavior after
bulbectomy are not caused by the loss of smell, as peripherally
induced anosmia does not generate depression like symptoms
(Song and Leonard, 2005). It is suggested that the bulbectomy
disrupts the limbic circuit responsible for flexible modulating of
behavior. Probably most important, after bulbectomy the tonic
inhibition of amygdala activity through the OB is reduced, result-
ing in a dysinhibition of the amygdala (McNish and Davis, 1997;
Harkin et al., 2003). The amygdala is basically involved in the pro-
cessing of emotional signals of threat and fear (LeDoux, 2007),
and further plays a central role in the physiopathology of depres-
sive disorders (Hamilton et al., 2012). Processing negative stimuli
is accompanied by hyperactivity of the amygdala (see Soudry
et al., 2011). Following these considerations, reduced olfactory
sensitivity might be due to dysfunctions of the OB in depressive
patients (Lu and Slotnick, 1998) and additionally, an impaired
OB can cause an intensified experience of sadness and fear via
disinhibition of the amygdala (Pause et al., 2001).
Individuals experiencing depression show a loss of interest or
pleasure in nearly all activities and describe their mood to be
sad, hopeless or discouraged. Their emotional experience is gen-
erally blunted, involving reduced experiences of positive as well as
of negative emotions. Here, we conclude that the reduced emo-
tionality during depressive states is accompanied by a reduced
olfactory experience. It is hypothesized that similar neuronal net-
works are responsible for the attenuated olfactory and emotional
experience. The olfactory environment is usually low in distinc-
tiveness and in general only few smells reach our awareness.
Therefore, it has been postulated that, in everyday life, olfaction is
a rather implicit sense (Köster, 2002). Considering, that a reduced
olfactory sensitivity contributes to a still lesser experience of envi-
ronmental smells, leads to the assumption that sadness might not
only to isolate individuals in terms of their emotional belonging-
ness, but also might isolate them with regard to reduced sensory
(olfactory) experiences.
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